GeNeuro's IPO

GeNeuro raised a round of funding on April 15, 2016. Investors include Public.

GeNeuro is a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, including multiple sclerosis (MS) and other diseases associated with human endogen…

Articles about GeNeuro's IPO: